These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 23159294)

  • 21. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
    Sethi MK; Hancock WS; Fanayan S
    Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
    Wang K; Huang C; Nice EC
    Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
    Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
    Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates.
    Mahasneh A; Al-Shaheri F; Jamal E
    Exp Mol Pathol; 2017 Jun; 102(3):475-483. PubMed ID: 28506769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and molecular features of young-onset colorectal cancer.
    Ballester V; Rashtak S; Boardman L
    World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research.
    Alves Martins BA; de Bulhões GF; Cavalcanti IN; Martins MM; de Oliveira PG; Martins AMA
    Front Oncol; 2019; 9():1284. PubMed ID: 31828035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.
    Kume H; Muraoka S; Kuga T; Adachi J; Narumi R; Watanabe S; Kuwano M; Kodera Y; Matsushita K; Fukuoka J; Masuda T; Ishihama Y; Matsubara H; Nomura F; Tomonaga T
    Mol Cell Proteomics; 2014 Jun; 13(6):1471-84. PubMed ID: 24687888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
    Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
    Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
    Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
    Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers.
    You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B
    J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development.
    Mikami T; Aoki M; Kimura T
    Curr Mol Pharmacol; 2012 Jun; 5(2):301-16. PubMed ID: 22122469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
    Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
    Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.